Related Experiment Videos
Ranitidine is effective therapy for erosive esophagitis
A R Euler1, R H Murdock, T H Wilson
1Glaxo Inc., Research Triangle Park, North Carolina.
The American Journal of Gastroenterology
|April 1, 1993
Summary
This study found that ranitidine, at 150 mg or 300 mg four times daily, effectively healed erosive esophagitis and relieved heartburn symptoms. Both dosages were well-tolerated and comparable to placebo in safety profiles.
Area of Science:
- Gastroenterology
- Pharmacology
Background:
- Erosive esophagitis is a condition characterized by esophageal inflammation and damage.
- Effective treatment options are needed to promote healing and alleviate symptoms like heartburn.
Purpose of the Study:
- To compare the efficacy and safety of two ranitidine dosages against placebo for treating erosive esophagitis.
- To evaluate the impact of ranitidine on symptom relief and endoscopic healing.
Main Methods:
- A multicenter, double-blind, randomized, placebo-controlled study.
- Adults with erosive esophagitis received ranitidine 150 mg q.i.d., ranitidine 300 mg q.i.d., or placebo for up to 12 weeks.
- Endoscopic evaluation assessed healing; symptom relief was also monitored.
Main Results:
- Significantly higher healing rates were observed with both ranitidine dosages compared to placebo at 8 and 12 weeks (p < 0.001).
- Ranitidine provided rapid and sustained heartburn relief within 24 hours.
- Both ranitidine dosages demonstrated safety profiles similar to placebo.
Conclusions:
- Ranitidine, at 150 mg or 300 mg four times daily, is an effective treatment for healing erosive esophagitis.
- Ranitidine offers significant symptom relief and is well-tolerated in patients with this condition.